NanoInk awarded grant to develop biomolecule nanoarray fabrication methods and platform

Aug. 22, 2006 – NanoInk Inc., a company specializing in nanometer-scale manufacturing and applications development in the life sciences and semiconductor industries, announced that it has been awarded a $735,000 Phase II Small Business Innovation Research grant from the National Human Genome Research Institute (NHGRI) of the National Institutes of Health.

The grant will be used to develop novel, biologically functional nanostructures that dramatically enhance the reproducibility, sensitivity, and spatial density of chip-based assays. To accomplish this objective, NanoInk said it will develop a patterning methodology based on its dip pen nanolithography technology to generate sub-micron sized features on solid surfaces.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.